Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation THT 2024

CMR in Ischemic Cardiomyopathy

Presenter: Jonathan Weinsaft

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation TCT 2023

TCT 741: Clinical Outcomes of Ischemic Cardiomyopathy vs. Non-Ischemic Cardiomyopathy in Women with Left Ventricular Assist Device

Presenter: Priyadarshini Dixit

October 25, 2023

Presentation THT 2023

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Presenter: Oleg Polonetsky

March 21, 2023

Presentation TCT 2022

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Presenter: Romy Hegeman

September 18, 2022

Presentation TCT 2017

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Presenter: Daniel Burkhoff, Samir R. Kapadia, Patrick Klein

November 01, 2017

Presentation CHIP Seattle 2017

Ischemic Cardiomyopathy: Medical Therapy and Devices

Presenter: Ryan C. Martin

August 10, 2017

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

Advertisement

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

CMR in Ischemic Cardiomyopathy

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

TCT 741: Clinical Outcomes of Ischemic Cardiomyopathy vs. Non-Ischemic Cardiomyopathy in Women with Left Ventricular Assist Device

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Ischemic Cardiomyopathy: Medical Therapy and Devices

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content